Sign In
Buy ALC
$64.22
-0.0600 (-0.0933%)
At Close: Jun 03, 2026
Is it the Right Time to Hold Alcon Stock in Your Portfolio Now?
09:45am, Thursday, 13'th Mar 2025
ALC stays on investors' radar due to its Surgical arm performance and contributions from new products.
Alcon to Host 2025 Capital Markets Day
09:02am, Thursday, 13'th Mar 2025
GENEVA--(BUSINESS WIRE)--Alcon to Host 2025 Capital Markets Day.
Algoma Central Corporation Takes Delivery of Three Vessels Within One Week
04:05pm, Friday, 07'th Mar 2025
ST. CATHARINES, Ontario--(BUSINESS WIRE)-- #yourmarinecarrierofchoice--Algoma Central Corporation (“Algoma”, “Company”) (TSX: ALC) has achieved a significant milestone, taking delivery of thre
Alcon Stock Gains From Innovation Despite Macroeconomic Troubles
12:20pm, Friday, 28'th Feb 2025
Within Vision Care, ALC is registering solid growth, banking on strong sales of its contact lenses and ocular health products.
Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters
09:02am, Thursday, 27'th Feb 2025
TORONTO--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the availability of expanded parameters for TOTAL30® for As
Watch CNBC's full interview with Alcon CEO David Endicott
08:54pm, Wednesday, 26'th Feb 2025
Alcon CEO David Endicott discusses the pharmaceutical firm's full-year results.
Alcon Inc. (ALC) Q4 2024 Earnings Call Transcript
11:51am, Wednesday, 26'th Feb 2025
Alcon Inc. (NYSE:ALC ) Q4 2024 Earnings Conference Call February 26, 2025 8:00 AM ET Company Participants Dan Cravens - Vice President, Investor Relations David Endicott - Chief Executive Officer Tim
Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in Afterhours
08:35am, Wednesday, 26'th Feb 2025
ALC's performance is driven by robust demand for its innovative products, balanced geographic footprint and strong execution by the team.
Alcon eyes revenue growth in 2025 after in-line results
02:13am, Wednesday, 26'th Feb 2025
Alcon forecast sales of between $10.2 and $10.4 billion for 2025, after the eye care group reported higher fourth-quarter revenue underpinned by its surgical division on Tuesday.
Alcon (ALC) Reports Q4 Earnings: What Key Metrics Have to Say
08:01pm, Tuesday, 25'th Feb 2025
While the top- and bottom-line numbers for Alcon (ALC) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare t
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
04:30pm, Tuesday, 25'th Feb 2025
GENEVA--(BUSINESS WIRE)--Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation.
GENEVA--(BUSINESS WIRE)--Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief with Its Longest Lasting Formula Yet.
Wall Street's Insights Into Key Metrics Ahead of Alcon (ALC) Q4 Earnings
10:20am, Thursday, 20'th Feb 2025
Evaluate the expected performance of Alcon (ALC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics fo
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
08:02am, Wednesday, 19'th Feb 2025
GENEVA--(BUSINESS WIRE)--Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension.
Algoma Central Corporation Announces a 5% Increase in Quarterly Dividend
07:00am, Friday, 17'th Jan 2025
ST. CATHARINES, Ontario--(BUSINESS WIRE)-- #yourmarinecarrierofchoice--Algoma Central Corporation (“Algoma” or “the Company”) (TSX: ALC), a leading provider of marine transportation services,
